New cholera vaccines.

Development of improved cholera vaccines has progressed rapidly in recent years. An oral killed vaccine, designed to evoke antibacterial as well as antitoxic intestinal immunity, has proved to be completely safe and to protect against cholera for at least 3 years. This vaccine also confers substantial though more short-lasting immunity against diarrhoea caused by enterotoxigenic Escherichia coli. Significant progress has also been made towards developing a live attenuated cholera vaccine using recombinant DNA techniques. The advent of effective oral cholera vaccines gives hope for improved control of cholera in the Third World.
AuthorsJ Holmgren, J Clemens, D A Sack, A M Svennerholm
JournalVaccine (Vaccine) Vol. 7 Issue 2 Pg. 94-6 (Apr 1989) ISSN: 0264-410X [Print] ENGLAND
PMID2665353 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Cholera Vaccines
  • Vaccines, Attenuated
  • Cholera Toxin
  • Administration, Oral
  • Cholera (etiology, immunology)
  • Cholera Toxin (immunology)
  • Cholera Vaccines (administration & dosage, immunology)
  • Clinical Trials as Topic
  • Humans
  • Intestinal Mucosa (immunology)
  • Public Health
  • Random Allocation
  • Recombination, Genetic
  • Time Factors
  • Vaccines, Attenuated

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: